Zenlabs Ethica Ltd

530697 Momentum

Overview

    • Equity Style Box

      Small Value

    • Sector

      Healthcare

    • Industry

      Medical Distribution

    • Day Range

      32.67 – 34.80

    • Year Range

      28.00 – 52.40

    • Market Cap

      226.5485 Mil

    • Volume / Avg

      13.0 / 9.5 k

    • Price / Sales

      0.38

    • Price / Book

      1.97

    • Price / Earnings

      60.90

    • Forward Div Yield

      0.00%

    • Trailing Div Yield

      —

Login To Show Full Chart

Summary

Fair Value Assessment
Momentum
Undervalued (29% Discount)
Fair ValueQ44.03UncertaintyHigh
Close Price31.06Mar 26, 2025
₹ 34.80
Price Up by 3.74 | 12.04 %
Trading Information Business Description
Previous Close
31.06
Day Range
32.67 – 34.80
Year Range
28.00 – 52.40
Bid / Ask
30.50 × 34.63
Market Cap
226.5 Mil
Volume / Average
13.0 / 9.5 k
Beta (5-Year)
0.04
Shares Outstanding
6.51 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.
Contact
Plot No.194-195 3rd Floor, Industrial Area, Phase-II, Chandigarh 160002
T +91 1724651105
www.zenlabsethica.com opens in a new tab
Sector
Healthcare
Industry
Medical Distribution
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
65
As of Mar 31, 2024

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
537.64 585.63 668.86 690.88 566.40 599.49
Revenue Growth %
-7.04% -12.44% -3.19% 21.98% -5.52% -10.92%
Gross Profit
141.53 147.75 135.82 126.94 99.12 104.90
Gross Profit Margin %
26.32% 25.23% 20.31% 18.37% 17.50% 17.50%
Operating Income
13.98 11.16 16.57 15.45 11.02 -9.75
Operating Margin %
2.60% 1.91% 2.48% 2.24% 1.95% -1.63%
EBIT
13.35 13.23 11.21 15.42 11.15 -9.98
EBIT Margin %
2.48% 2.26% 1.68% 2.23% 1.97% -1.67%
EBITDA
26.10 26.17 23.70 24.33 13.89 -7.06
EBITDA Margin %
4.85% 4.47% 3.54% 3.52% 2.45% -1.18%
Net Income
3.31 4.21 4.89 8.23 8.32 -7.33
Net Profit Margin %
0.62% 0.72% 0.73% 1.19% 1.47% -1.22%
Basic EPS
0.51 0.65 0.75 1.26 1.28 -1.13
Diluted EPS
0.51 0.65 0.75 1.26 1.28 -1.13
Normalized EPS
— — — — — —
Total Dividends per Share
— — 0.25 — — —
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
404.67 402.58 434.93 378.99 321.11 339.94
Total Liabilities
302.03 301.35 337.90 285.25 236.92 265.83
Total Debt
113.43 148.60 58.44 39.03 25.99 15.45
Total Equity
102.63 101.23 97.04 93.75 84.19 74.11
Cash And Cash Equivalents
13.97 9.05 0.55 0.12 15.34 15.28
Working Capital
87.49 85.25 80.55 73.00 65.06 59.38
Shares Outstanding (Mil)
— — 6.51 — — 6.51
Book Value Per Share
— 15.55 14.91 14.40 12.93 11.38
Total Debt To Equity
1.11 1.47 0.60 0.42 0.31 0.21
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-12.84 -90.61 15.20 -3.80 1.56 4.53
Cash From Investing Activities
2.04 1.09 -14.68 0.02 -4.61 0.05
Cash From Financing Activities
18.09 82.38 0.60 3.13 -1.28 -0.32
Capital Expenditures
— 0.22 15.46 0.27 6.15 0.53
Free Cash Flow
— 19.83 9.86 22.34 4.97 -5.52
Change in Cash
7.29 -7.13 1.12 -0.65 -4.33 4.26

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

STOCKS
MUTUAL FUNDS
ADITYABIRLAAXISBajajBANDHANBARODABNPBOICANARADSPEDELWEISSFRANKLINTEMPLETONGROWWHDFCHELIOSHSBCICICIIIFLINVESCOITIJMKOTAKLICMahindraManulifeMIRAEMOTILALNAVINipponNJOldBridgePGIMPPFASQUANTQUANTUMSAMCOSBISHRIRAMSUNDARAMTATATAURUSTrustUNIONUTIWhiteOakZERODHA
INSURANCE FUNDS
ABSLAEGONAGEASFEDERALAVIVABAJAJALLIANZBHARTIAXACANARAHSBCORIENTBANKEDELWEISSTOKIOEXIDEFUTUREGENERALIHDFCICICIPRUDENTIALINDIAFIRSTKOTAKMAHINDRALICMAXLIFEPNBMETLIFEPRAMERICARELIANCENIPPONSAHARASBISHRIRAMSTARUNIONDAI-ICHITATAAIA

About Us

Connect With Us

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top